![Immune Network Ltd Logo](/news-release/logo/214799/0/214799.jpg?lastModified=12%2F09%2F2016%2023%3A15%3A24&size=2)
Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial
December 30, 2010 04:41 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01 clinical...
![Immune Network Ltd Logo](/news-release/logo/214799/0/214799.jpg?lastModified=12%2F09%2F2016%2023%3A15%3A24&size=2)
Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5
November 14, 2010 23:21 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 14, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has announced the completion of...